Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04348227
What this trial is testing

How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?

Who this might be right for
Ventilator Associated Pneumonia
Hôpital Universitaire Fattouma Bourguiba 120
Early research (Phase 1)Study completedNCT05181683
What this trial is testing

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Large-scale testing (Phase 3)Study completedNCT04435379
What this trial is testing

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic

Who this might be right for
Infection, Respiratory Tract
Serum Life Science Europe GmbH 2,038
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Not applicableStudy completedNCT06917261
What this trial is testing

Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample

Who this might be right for
SARS-CoV-2 Infection
University Hospital, Grenoble 400
Not applicableStudy completedNCT05178173
What this trial is testing

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)

Who this might be right for
COVID-19Coronavirus InfectionSARS CoV 2 Infection
University of North Carolina, Chapel Hill 230
Testing effectiveness (Phase 2)Study completedNCT06437223
What this trial is testing

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Who this might be right for
Long COVID
Inflammx Therapeutics Inc 16
Testing effectiveness (Phase 2)Study completedNCT05596734
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

Who this might be right for
Influenza, HumanCOVID-19
BioNTech SE 1,019
Testing effectiveness (Phase 2)Study completedNCT04335084
What this trial is testing

Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

Who this might be right for
COVID-19Coronavirus InfectionSars-CoV2+5 more
ProgenaBiome 254
Testing effectiveness (Phase 2)Study completedNCT04551911
What this trial is testing

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Who this might be right for
COVID-19CoronavirusSARS-CoV2 Infection
OPKO Health, Inc. 171
Not applicableUnknownNCT04977934
What this trial is testing

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19

Who this might be right for
COVID-19 Pneumonia
Charite University, Berlin, Germany 94
Early research (Phase 1)Study completedNCT04535167
What this trial is testing

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

Who this might be right for
Viral Disease
Pfizer 26
Not applicableWithdrawnNCT04480411
What this trial is testing

Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients

Who this might be right for
Diagnoses DiseaseCovid19
Stanford University
Not applicableStudy completedNCT04413058
What this trial is testing

Menstrual Cycle Characteristics of Healthcare Professionals

Who this might be right for
Menstrual IrregularityCovid 19
Haydarpasa Numune Training and Research Hospital 260
Not applicableActive Not RecruitingNCT04568148
What this trial is testing

COVID-19 Biorepository

Who this might be right for
Covid-19SARS-CoV 2Coronavirus+1 more
University of Kansas Medical Center 201
Not applicableEnded earlyNCT04377165
What this trial is testing

Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities

Who this might be right for
COVIDInfluenzaGastroenteritis
The University of Queensland 34
Not applicableStudy completedNCT05113836
What this trial is testing

LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2

Who this might be right for
SARS-CoV2 Infection
Assistance Publique - Hôpitaux de Paris 89
Testing effectiveness (Phase 2)Study completedNCT04533399
What this trial is testing

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 4,422
Not applicableActive Not RecruitingNCT04853004
What this trial is testing

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations

Who this might be right for
SARS-CoV 2
Karolinska Institutet 10,000
Next Page